Boston Children's Hospital Dana Farber Cancer Institute
The Agarwal lab aims to develop innovative therapies – using novel medications or a patient's own cells - for patients with genetic blood disorders....
Dana-Farber Cancer Institute Boston Children's Hospital Harvard Medical School | Broad Institute of MIT and Harvard
Scott Armstrong studies the mechanisms of cancer development, focusing on leukemia. One major interest of this lab is the relationship between leukemia,...
Dana-Farber/Boston Children's Hospital Harvard Medical School
Alessandra Biffi is actively involved in gene therapy trials for genetic diseases of childhood. Her research focuses on enhancing the efficacy of HSC-based...
Joslin Diabetes Center Harvard Medical School Department of Genetics
Using the model organism C. elegans, we study how regulatory pathways that are important in growth control influence stress defenses and aging, as well...
Boston Children's Hospital Dana-Farber Cancer Institute
Alan Cantor aims to understand the gene regulatory mechanisms involved in normal blood cell development, and to understand how their dysregulation leads...
Beth Israel Deaconess Medical Center Harvard Medical School Wyss Institute for Biologically Inspired Engineering
Elliot Chaikof promotes alliances of clinicians, engineers, chemists, and biologists, in the process developing biologically inspired materials, devices...
Massachusetts General Hospital Harvard Medical School
The Pediatric Surgical Research Laboratories focus on Developmental Biology, some areas of which hold promise for clinical application to benefit both...
The Dymecki lab studies how functional modularity arises within the brain serotonergic neuronal system and dynamically controls diverse processes ranging...
Brigham and Women's Hospital Dana-Farber Cancer Institute Harvard Medical School
Fatty liver disease affects >90 million people in the U.S., chronic liver is the 12th leading cause of death, and liver cancer is one of the fastest...
The mission of the Humphreys Lab is to understand the cellular and molecular mechanisms of kidney injury and repair and to translate this knowledge into new therapeutic strategies to treat patients suffering from kidney disease.... Read more about Benjamin Humphreys, MD, PhD
